Hypertrophic effect of inhaled beta2-agonist with and without concurrent exercise training: A randomized controlled trial
Hypertrophic effect of inhaled beta2-agonist with and without concurrent exercise training: A randomized controlled trial
复制标题
DOI:
10.1111/sms.13221
复制
发表时间:
2018-10-01
影响因子:
4.1
通讯作者:
Hostrup, M.
中科院分区:
文献类型:
--
作者:
Jessen, S.;Onslev, J.;Hostrup, M.
Due to a high prevalence of asthma and exercise-induced bronchoconstriction in elite athletes, there is a high use of beta(2)-adrenoceptor agonists (beta(2)-agonists) in the athletic population. While anabolic in rodents, no study has been able to detect hypertrophy in humans after chronic beta(2)-agonist inhalation. We investigated whether inhaled beta(2)-agonist, terbutaline, alters body composition and metabolic rate with and without concurrent exercise training in healthy young men. Sixty-seven participants completed a 4-week intervention of daily terbutaline (8x0.5mg) or placebo treatment without concurrent training (habitual; n=23), with resistance (n=23) or endurance (n=21) training 3 times weekly. Before and after the interventions, participant's body composition was determined by dual-energy X-ray absorptiometry and resting metabolic rate and substrate oxidation by indirect calorimetry. Terbutaline increased lean body mass by 1.03kg (95% CI 0.29-1.76; P